Telehealth is one of the rare sectors reaping a net positive effect of Covid-19. They say that “In the midst of every crisis lies a great opportunity” - Could Covid-19 be the opportunity telehealth has been waiting for?
It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines?
This is your monthly digest of three noteworthy news stories in digital health from the last few weeks - what they mean for the industry, and why you should know about them.
For anyone in the business of digital health, it is difficult not to pay attention to the patient data debates fought out daily in the news.
In this week's blog we map some of the emerging subsegments of digitally enabled mental health and the evidence and partnerships contributing to the growing maturity of this central tenet of human health and care.
This is your monthly digest of two noteworthy news stories in digital health from the last few weeks - what they mean for the industry, and why you should know about them.
For our first podcast of 2020, we talk to the Venture Valkyrie herself, Lisa Suennen.
We started our conversations on the digital opportunity for clinical trials at the HealthXL Global Gathering in September 2019. And after many months of exchanges, debates, and conversation, our long-awaited report on Clinical Trial Optimization is finally here!
This is your monthly digest of three noteworthy news stories in digital health from the last few weeks - what they mean for the industry, and why you should know about them.
As we enter 2020, we take a look back at some notable digital health developments from 2019 and give our take on what we think you should be keeping an eye on this year.
In the last HealthXL blog of the decade we share some of the highs and lows that set the scene for healthcare progress in 2020. Read on for the roundup of 2019 and keep your eyes peeled for our first blog of 2020 that will map out the trends we predict will dominate the year to come
In this week’s podcast we chat to Abhishek Shah, CEO of Wellthy Therapeutics, who talks to us about being the black sheep of the family and finding his calling as a healthcare entrepreneur.
Digital health advancements should benefit all of us. However, the benefits of digital advancements are not equally distributed. This week, we take a look at some of the shortfalls of digital transformation and review examples of solutions embedding inclusivity in their design and delivery.
Not all digital health products are the same. But what are their differences? How should each product be used? How much evidence is needed to go to market? What type of clinical evidence or regulatory oversight is necessary? Clarity matters. Here’s what you need to know.
John Brownstein is the Chief Innovation Officer of Boston Children's Hospital. Boston Children’s Hospital is one of the first to use Alexa and voice technology in the homes of their patients. This discussion with John coincided with Alexa becoming HIPAA compliant.
A descriptive overview of the roundtable sessions held in Melbourne earlier this year with our Australian memebers - MCRI, CSIRO, Bupa, Novartis, Medibank and ANDHealth.
Part one of our debrief following the Ignite Melbourne event held at MCRI in Melbourne earlier in the year. Learn who eas there and what was discussed.
Chris Coburn, Partners Healthcare and an old friend of HealthXL talks to us about how growing up in a large healthcare family and the journey that led him to his current role as Chief Innovation Officer.
This week, in collaboration with HealthXL member Jeff Gombala (ZS Associates), we discuss the potential of digital health solutions to address the social determinants of health.
The Digital Health Evidence Review 2019 report aims to identify, categorize, and summarize all existing, relevant studies in digital health. In this report, we have to established a clear understanding of the existing body of clinical evidence for digital health, its maturity, current gaps and needs
Eugene Borukhovich is disrupting healthcare! In this episode you will learn why, how and what is driving him. He unveils his thoughts on the American PBM model, on changing dynamics, innovative pharma companies, margins on digital health assets, his favorite start-ups and more!
The HealthXL platform was launched this month, in this blog we discuss why we built it, how our members use it today and our vision for where we’re taking it next.
A monthly digest of three noteworthy news stories in digital health from the past month - what they mean for the industry, and why you should know about them.
Megan is the Founder and Executive Director of the Digital Therapeutics Alliance (DTA). The DTA has really taken off in the last few years as the cohort of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics.
Our upcoming HealthXL Research report aims to identify, categorize, and summarize all existing, relevant studies in digital health. Through this report, we want to establish a clear understanding of the existing body of clinical evidence for digital health, its maturity, current gaps, and needs.
People living with addiction disorders have long been an underserved population in healthcare. This week we look at how digital tools are supporting accessible and unbiased support for smoking cessation, opioid use disorders, and alcoholism.
An analysis of the consumer diagnostic space, looking at the top funded companies, partnerships, notable activity etc, using the data from our HealthXL platform. We explore the biggest companies that are selling diagnostic kits direct to consumer.
Three noteworthy news stories in digital health from the past month - what they mean for the industry, and why you should know about them.
Episode #2 of the HealthXL podcast meets with Robert Garber of 7wire ventures. The conversation spins from lessons learned to life hacks that shaped his career and how he does business today .
60% of China’s 1.4 Billion population will be living in an urban setting by 2030, so their pole position on the smart cities front is hardly surprising. What are some of the notable activity happening on the ground and to what extent can these efforts help improve population health outcomes?
In this weeks blog, we are doing a roundup of some notable investments that have occurred so far in 2019, assessing the types of companies that are catching the interest of investors, and exploring if these correlate to our previous predictions or if there are any new trends to add to your radar.
Moving past investments in digital health, we are now starting to be asked about returns.What is the ROI on Digital Health? Return on investment (ROI) is king in every sector, healthcare not spared and we want to see finacial results.
Episode #1 of HealthXL's Digital Health podcast, featuring Bill Zeruld from Otsuka Pharmacueticals.
There are 3.3 million unique genes in the human gut, 150 times more genes than the human genome - basically, we are more microbiome than we are human. This week we take a dive into the flourishing microbiome space and digital interventions supporting its scale to supercharge personalized healthcare.
We recently released our Q1 report on Virtual Health Assistants (VHAs). As part of the report, we carried out a survey on consumers and clinicians. In this weeks blog, we examine the results of our survey to gain an insight into consumer and clinician awareness, adoption, and trust in VHAs.
Primary care is the healthcare provided in the community for people making an initial approach to a medical practitioner or clinic for advice or treatment and it's undergoing major change internationally. In this blog we explore how digital can support and improve the delivery of care.
In this weeks blog, we take a look at how the unprecedented public interest in the Theranos case has impacted the digital health space, sparking questions around digital health valuations, due diligence, and clinical evidence.
There is a modern day gold rush happening in China. The environment is prime for digital health and healthcare innovation, something pharma decision makers know well - an awareness that is now being explicitly demonstrated. Here is an introductory insight into why the Chinese market is appealing.
Few people trust their health insurance company. The numbers are unsurprising. According to a 2017 Revive Health survey 79% of consumers trust their doctors whilst only 69% reported trusting their insurers.This week we take a look at the emerging next gen payers.
In this weeks blog, we explore why the ‘gold standard’ RCT in its current form is not necessarily the perfect fit for evaluating digital health solutions, and what some appropriate alternatives may be.
The frenetic M&A activity in healthcare is rather disorienting and difficult to keep up with. We’ve rounded up the key themes we are seeing and what this may mean for all of us.
2018 was quite the year for M&A activity in healthcare. Some big announcements made waves such as the Amazon-PillPack, Roche-Flatiron, Cigna-Express Scripts, CVS-Aetna, ResMed-Propeller deals, there were hundreds of smaller ones too. We dig into what the ResMed - Propeller deal could mean for all.
We’ve put together a list of 8 digital health trends to keep on your radar in 2019 based on everything we’ve read and heard from our members, advisors, friends at start-ups, and investors, coupled with data from the HealthXL platform to bring you a perfect mix of subjective and objective data.
We are at the begining of a new chapter in digital health and plan to excede your expectations in 2019. Join the tribe and be at forefront of innovation and change in healthcare.
We look back at the highlights from HealthXL in 2018. Events we hosted around the world, reports we published with expert insight as well as webinars, blogs and staying ahead of trends throughout the year.
The best of digital health 2018 drew factors from trending topics, community interest and positive feedback where content provided insights that benefited our readers in their relevant fields.
We're rounding up the most popular posts of the year as we bid adieu to 2018. We have analysed key trends and member favourites so we can bring you more great content next year.
This week we take look at the implications of electronic patient reported outcome (ePROs) interventions and some notable partnerships and evidence behind these solutions. Is this the future of routine cancer care? We think so. Read on to find out why:
In this week’s blog, we look at how digital health can play a role in clinical trials - from patient recruitment, to helping patients control their own trial experience, to collecting more regular and more accurate data from the trials.
Silicon Valley is known around the world as the center for technology innovation. In this blog post, we have used investment as a proxy for innovation to understand if maybe Silicon Valley has overstayed its welcome and is now paving the way for other tech innovation hubs in the USA and abroad.
The FDA and European commission have taken some big steps as a response to the burgeoning digital health market, while still trying to fulfill its mission of protecting public health. In this blog, we look at American and European initiatives in putting some structure on the regulation of SaMDs.
This week we take a look at some of the notable healthcare activities Google and Apple have engaged in so far to provide insight into their healthcare strategies and where healthcare incumbents may be challenged or where healthcare organisations may stand to benefit from the precedent.
Adequate payment for a digital health solution is essential to becoming successful and driving mainstream adoption. In this week's blog, we investigate which solutions are actually generating revenue, why and what business models have worked.
Rapidly proliferating evidence-based digital health solutions, bigger data sets, more advanced analytics tools and some of the areas discussed above are categorically changing the face of healthcare payments
Is Alexa the new voice of healthcare delivery? She can give information about the weather, the news, play music, tell jokes, etc, surely she can solve your health woes, right? Maybe not just yet. Alexa won’t change healthcare delivery until she is HIPAA compliant.
From a corporate environment, working with accelerators, to becoming an accelerator, working with other accelerators - Martin Kelly CEO of HealthXL gives his account of the journey that led his company out of infancy to a global operation working with 5 of the top 5 pharma's in the world.
Digital innovations that are unleashing the power of technology to fundamentally change how patient care is delivered in India. These innovations span across a wide range of areas such as telemedicine, appointment management, e-pharmacies and adherence tracking.
As we progress into a new health paradigm of personalisation and prevention we are being forced to consider how we can make data more accessible for consumers, ensure privacy and facilitate interoperability. Enter Blockchain.
Scott Weiner MD, Assistant Professor of Emergency Medicine at Brigham and Women's Hospital who has spent many years researching and advocating for solutions to curb the opioid epidemic explains why he became interested in the topic, how hospitals can more effectively deal with this crisis.
We outline the stories of two very different humans whose paths cross given their relationship as patient and physician. You can see the problem of addiction and the hardships in treatment (even if very evidence-based) through their eyes.
While technology is already transforming transportation and infrastructure systems in cities around the world, people are now recognising its potential to also tackle the health and environmental challenges associated with city living.
Digital health continues to attract significant new investment dollars and drive lots of M&A activity, however there is a lot of hype and confusion about how it will reshape healthcare delivery and impact the life-science industry.
FemTech is a rapidly growing area of digital health targeted at women’s health and wellness - from rapid diagnostics and to remote monitoring, and beyond. We looked at some of the most promising Reproductive and Maternal focused FemTech solutions
Medical education needs a bit of shaking up, and medical schools are beginning to innovate to prepare new physicians for the emerging new model of care.
There has been much hype around healthcare consumerism lately, with direct-to-consumer digital health and wellness apps coming into the market at unprecedented rates - But can we really trust patients to filter through this noise and find true value?
Despite billions and billions of dollars of investment, Digital Health is still searching for great examples of how it can improve the patient experience and deliver improved healthcare outcomes.
They say necessity is the root of all innovation - or at least, innovation should be routed in addressing a real need. Read on for an insight into the most promising digitally enabled healthcare innovations in emerging markets.
Digital therapeutics is at an inflection point in its hype cycle progression and has quickly begun to demonstrate its true potential as a solidified new category in healthcare today.
Murdoch Children’s Research Institute’s (MCRI) newly released HeadCheck app is an example of how digital tools can help combat the problem of concussions.
GDPR is set to place a greater responsibility on companies to actively engage with the people whose data they are processing, the healthcare industry will be impacted by a new paradigm on how privacy, personal information and consent are managed.
How do novel technologies such as robotics, telemedicine & vehicle interfaces extend the safety & independence of older adults? We took a look at how is being used to improve the well-being of an aging population.
The United States is in the midst of the worst drug crisis in the nation’s history, a toll measured in fatalities on a scale never seen before. With a record-setting 42,000+ drug overdose deaths involving an opioid in 2016.
In recent years pharmaceutical companies are turning to AI and Deep Learning to support their research to develop drugs. We took a look at some of the high profile deals, partnerships and collaborations in the past few years.
We have gone from genome sequencing costing a whopping $10M in 2007 to as little as $79 in 2018. It is important to stay focused on real integration into clinical settings for broader population health. Enter GenomeAsia and Genomics England.
The rise of precision medicine, the movement of customized healthcare for all, is driving the growth of medical 3D printing. we reach out to our community to gather their expert perspectives
You’re the person responsible for bringing innovation to a health system that cannot sustain expanding aging populations, chronic diseases, and worrying cancer trends, without the opportunity offered by digital health. What keeps you up at night?
Five billion people worldwide do not have access to safe surgical services. Surgical diseases cause more death worldwide than HIV/AIDS, TB & Malaria combined. Using digital technology, we may enable surgeons to deliver safe surgical care for everyone
News and hype surround the field of radiology with headlines around the world purporting that it will be disrupted overnight. Few companies though really have the evidence to back up these claims.
Digital patient reported outcomes (or ePROs) are one area of digital health showing significant promise. These solutions are showing evidence of efficacy on the basis of timely communication, simple technology solving a complicated problem.
The opioid crisis in the US is known to all in the health industry. We decided to launch a Task Force to gain a better perspective of the problem and potential technology enabled solutions from a multitude of stakeholders.
We brought together a multi-stakeholder group of experts who commented on key questions relating to the disruptive possibilities of virtual pharmacies on traditional retail pharmacies as well as other areas within the healthcare ecosystem.
The promise of Artificial Intelligence to transform the healthcare industry is as bold as ever, but, is this promise being delivered on? We conducted an analysis of adoption in pharmaceuticals/life sciences, care delivery, and the payor space.
José Pedro Almeida, Director of Big Data Analytics & Machine Learning is confident that we leverage technologies such as Machine Learning or Big Data Analytics to help physicians and nurses save more lives.
Naomi Fried, PhD and Founder & CEO of Health Innovation Strategies givers her insights on what an innovative culture looks like.
In a data-rich world, digital biomarkers have the potential to reduce costs, and improve patient outcomes. We took a look at some of the innovations and companies that are developing the solutions of tomorrow.
Precision medicine will help us move from a "one fits all approach” of healthcare, to instead moving towards a more customized individual focus to improve patient outcomes. We look at some startups leading the way.
The applications of sensors in the digital health space were previously limited by their large size and front end electronic but this no longer the case. Check out how sensors can be deployed to quantify, monitor, diagnose, and gamify our health.
Our current model of care is coming under increasing pressure to adapt to the needs of our growing ageing population. Check out some of the companies that are striving to reduce the number of hospital admissions among seniors.
Virtual Reality has already made incredible strides within media and entertainment . We asked ourselves, what about Healthcare? How is VR technology being used, and who is using it?
With DNA data becoming more affordable for companies to obtain, the consumer genomics industry is looking set to really gain momentum. Let’s explore the landscape and take a look at what it can do?
Big data, artificial intelligence, predictive analytics are all becoming increasingly familiar to the healthcare industry. Blockchain however, is still a bit of a mystery. Today were going to take a quick look at what exactly is blockchain?
We explore digital health organizations leading the way with clinical evidence
Roundup of the most interesting stories in digital health this week
Insights from Peter Chai MD on adherence tracking devices
The key innovation opportunities highlighted by Dr. Ameet Bakhai during our Digital Heart Health webinar.
We spoke with our members about how they evaluate digital health solutions as a customer rather than an investor. We used the feedback to produce scoresheet around the attributes they value